Herndon Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-89
Closed -$7K 402
2016
Q3
$7K Hold
89
﹤0.01% 201
2016
Q2
$7K Buy
+89
New +$6.7K ﹤0.01% 199
2014
Q2
Sell
-33,367
Closed -$1.96M 170
2014
Q1
$1.96M Sell
33,367
-34,531
-51% -$1.93M 0.03% 90
2013
Q4
$3.46M Sell
67,898
-20,841
-23% -$1.04M 0.04% 82
2013
Q3
$4.47M Sell
88,739
-19,882
-18% -$1.04M 0.06% 68
2013
Q2
$5.34M Buy
+108,621
New +$5.91M 0.08% 64

Other funds holding LLY

Herndon Capital Management's LLY Position: Q4 2016 in Review

Herndon Capital Management sold out of Eli Lilly (LLY) in Q4 2016, closing a stake of 89 shares — an estimated $7K sold.

Herndon Capital Management first reported a position in LLY in Q2 2013 and held it in 6 quarters. The position peaked at $5.34M in Q2 2013. 1,212 funds tracked by Wall St. Rank hold LLY as of Q4 2016.

  • Herndon Capital Management reported no remaining Eli Lilly position as of Q4 2016 after selling out during the quarter.
  • Herndon Capital Management sold 89 Eli Lilly shares in Q4 2016, an estimated $7K.
  • Herndon Capital Management first reported a position in Eli Lilly in Q2 2013 and held it in 6 quarters.
  • Herndon Capital Management's Eli Lilly position peaked at $5.34M in Q2 2013.
  • 1,212 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2016.

Based on Herndon Capital Management's 13F filing for Q4 2016, filed 2 Feb 2017.